Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model (Q35912726)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 21 May 2007

Language	Label	Description	Also known as
English	Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model	scientific article published on 21 May 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

L Garcia-Contreras

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

J Fiegel

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

M J Telko

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

K Elbert

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

A Hawi

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

M Thomas

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

J VerBerkmoes

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

W A Germishuizen

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

P B Fourie

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

A J Hickey

10

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

D Edwards

11

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

21 May 2007

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

51

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

2830-2836

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

11 July 2018

Treatment and prevention of multidrug-resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

11 July 2018

Eleven Years of Community-Based Directly Observed Therapy for Tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

11 July 2018

Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

11 July 2018

Host-parasite relationships in experimental airborne tuberculosis. 3. Relevance of microbial enumeration to acquired resistance in guinea pigs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

11 July 2018

The auditory, vestibular and renal effects of capreomycin in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

11 July 2018

Capreomycin in the treatment of pulmonary tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

11 July 2018

Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

11 July 2018

Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

24 September 2018

UV spectroscopy and reverse-phase HPLC as novel methods to determine Capreomycin of liposomal formulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

24 September 2018

Direct lung delivery of para-aminosalicylic acid by aerosol particles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

24 September 2018

The impurities of capreomycin make a difference in the safety and pharmacokinetic profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

24 September 2018

Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

24 September 2018

Airways delivery of rifampicin microparticles for the treatment of tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

24 September 2018

Multiple drugs in retreatment of chronic pulmonary tuberculosis. Results with capreomycin and ethambutol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

24 September 2018

Absorption, excretion and metabolism of capreomycin in normal and diseased states

1 reference

https://pubmed.ncbi.nlm.nih.gov/17517845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capreomycin kinetics in renal impairment and clearance by hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17517845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large porous particles for pulmonary drug delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/17517845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined immunomodulating effects of BCG and Lentinan after intranasal application in guinea pigs

1 reference

https://pubmed.ncbi.nlm.nih.gov/17517845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization

1 reference

https://pubmed.ncbi.nlm.nih.gov/17517845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capreomycin in the re-treatment of patients with pulmonary tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17517845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.01164-06

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35912726&oldid=1773618706"